IDEAYA Biosciences (IDYA) Other Working Capital Changes (2018 - 2026)
IDEAYA Biosciences' (IDYA) quarterly Other Working Capital Changes came in at $686000.0 in Q1 2026, down 87.67% quarter-over-quarter from $5.6 million in Q4 2025.
IDEAYA Biosciences (IDYA) Other Working Capital Changes (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has disclosed Other Working Capital Changes across 9 years of filings, most recently posting $686000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $686000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $13.7 million (up 106.67% YoY), and the FY2025 annual result was $52726.0, down 99.14% from the prior year.
- Other Working Capital Changes came in at $686000.0 for Q1 2026 at IDEAYA Biosciences, down from $5.6 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $14.4 million in Q4 2023 to a low of -$11.4 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is -$122702.5 (2024), against an average of $801878.7.
- Peak annual rise in Other Working Capital Changes reached 755.36% in 2023, while the deepest fall reached 965.25% in 2023.
- IDEAYA Biosciences' Other Working Capital Changes stood at -$2.2 million in 2022, then jumped by 755.36% to $14.4 million in 2023, then tumbled by 48.17% to $7.4 million in 2024, then dropped by 25.26% to $5.6 million in 2025, then slumped by 87.67% to $686000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $686000.0 (Q1 2026), $5.6 million (Q4 2025), and $42464.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 686,000.00 |
| Mar 31, 2026 | 686,000.00 |
| Dec 31, 2025 | 5.56 Mn |
| Dec 31, 2025 | 5.56 Mn |
| Sep 30, 2025 | 42,464.00 |
| Sep 30, 2025 | 42,464.00 |
| Jun 30, 2025 | 34,595.00 |
| Jun 30, 2025 | 34,595.00 |
| Dec 31, 2024 | 7.44 Mn |
| Dec 31, 2024 | 7.44 Mn |
| Sep 30, 2024 | -280,000.00 |
| Sep 30, 2024 | -280,000.00 |
| Jun 30, 2024 | -538,000.00 |
| Jun 30, 2024 | -538,000.00 |
| Mar 31, 2024 | -465,000.00 |
| Mar 31, 2024 | -465,000.00 |
| Dec 31, 2023 | 14.36 Mn |
| Dec 31, 2023 | 14.36 Mn |
| Sep 30, 2023 | -11.40 Mn |
| Sep 30, 2023 | -11.40 Mn |